News

Issued by ModeX Therapeutics Inc., not Regeneron Pharmaceuticals, Inc.

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

October 29, 2025 · Published on GlobeNewswire

It isn’t one of Regeneron Pharmaceuticals, Inc.’s news releases, so 6ix doesn’t show it on Regeneron Pharmaceuticals, Inc.’s page or send it as an alert.

Go to Regeneron Pharmaceuticals, Inc. on 6ix